advertisement

---

Anraku A 1

Showing records 1 to 1 | Display all abstracts from Anraku A

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Tsukahara S; Enomoto N; Ishida K; Anraku A; Tomita G
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---